Market Access Analyst

3 years exp **Roles & Responsibilities** **Job brief** Market Research Analyst to support South East Asia region pharma, medical device and aesthetic products, to survey customer preferences and statistical data in order to make recommendations to business priorities, support customers during their decision making process regarding product designs, prices and promotions. The successful market researcher will be able to analyze autonomously qualitative data, trends, strategies and competition aiming at increasing competitiveness. **Responsibilities** - Collect data on consumers, competitors and market place and consolidate information into actionable items, reports and presentations - Understand business objectives and design surveys to discover prospective customers’ preferences - Compile and analyze statistical data using modern and traditional methods to collect it - Perform valid and reliable market research SWOT analysis - Interpret data, formulate reports and make recommendations - Use online market research and catalogue findings to databases - Provide competitive analysis on various companies’ market offerings, identify market trends, pricing/business models, sales and methods of operation - Evaluate program methodology and key data to ensure that data on the releases are accurate and the angle of the release is correct - Remain fully informed on market trends, other parties researches and implement best practices **Requirements**: - Proven Market Research Analysis experience in pharmaceuticals and/or medical devices - Ability to interpret large amounts of data and to multi-task - Strong communication and presentation skills - Excellent knowledge of statistical packages (SPSS, SAS or similar), databases and MS Office - Search engines, web analytics and business research tools acumen - Familiarity with CRM programs - Adequate knowledge of data collection methods (polls, focus groups, surveys etc) - Working knowledge of data warehousing, modelling and mining - Strong analytical and critical thinking - BS degree in Statistics, Marketing or related field CMS Biotech Pte Ltd, a subsidiary of China Medical System Holdings Ltd. China Medical System Holdings Limited (“CMS”, together with its subsidiaries, the “Group”) is a well-established, innovation-driven specialty pharma with a focus on sales and marketing in China, dedicated to offering competitive products and services to meet China's unmet needs for health and beauty. The Group focuses on innovative products that are global first-in-class, or with the best efficacy, safety or cost-effectiveness in the class due to their innovative formulations or drug delivery systems, and has built an innovative product pipeline with relatively high innovation level, good market potential and competitive differentiation advantages. Meanwhile, the Group has proven and successful experience in drug commercialization and strong capability in professional academic promotion, having created a leading market position for many existing drugs and facilitated the clinical development of innovative drugs in China. Jointly driven by the strong product competence, the powerful academic promotion capability, and the refined internal management system, the Group has sustained rapid growth and become one of the Chinese pharmaceutical companies with the highest operating efficiency. Capitalizing on its own advantages, the Group constantly expands the business boundaries and rapidly promotes the development of new businesses, which consist of the dermatology and medical aesthetic business (CMS Aesthetics) and the healthcare business (CMS Health), while making in-depth development in multiple fields of expertise. CMS Aesthetics specializes in the development of dermatological drugs and medical aesthetic solutions, dedicated to becoming the largest and most professional company in the field of dermatology, medical aesthetics and health management in China. CMS Health stringently selects functional quality healthcare products with unique ingredients globally according to medical concept and high standards, to improve the sub-health status of Chinese consumers through one-stop cross-border e-commerce platforms. With the prudent and professional management style and continuous performance growth, the Group has won several recognitions from the capital market: it has made Forbes lists for six times and awarded a number of honors such as the "Best Hong Kong Stock-Connect Company", "Listed Company with the Best Information Disclosure", "Best Listed Company", "Best Investment Value Award for Listed Companies", "Most Valuable Pharmaceutical Listing Company", "Best Investor Relations", "Hong Kong Stock-Connect Company with the Most Substantial Growth Potential", "Benchmarking Enterprises in Pharmaceutical Industry at the 70th Anniversary of PRC Founding", "Top 100 Innovative Pharmaceutical Enterprises in China", etc.